Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kurt Schmidt, Henk Viëtor

Premium

Kurt Schmidt has been appointed CEO of Skyline Diagnostics. Schmidt joins Skyline from Agendia, where he had served as chief financial officer since 2009. Before Agendia, Schmidt was operations director at B2eMarkets and he was director of finance and operations at LA Gear Europe. In connection with Schmidt's appointment, Skyline's former CEO Henk Viëtor has been appointed to the supervisory board of the Rotterdam, Netherlands-based company.

In a statement, Skyline noted that Agendia is "not dissimilar" to itself, as it has also commercialized microarray-based tests for cancer. The firm also said that it is "entering a new phase" with Schmidt's appointment. Skyline achieved a CE-IVD mark for its AMLprofiler test in 2011 and is conducting clinical trials for an eventual US Food and Drug Administration submission (BAN 3/15/2011).

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.